SLU-PP-332 5MG

SLU-PP-332 5MG | ESTROGEN-RELATED RECEPTOR (ERR) AGONIST

SLU-PP-332 is a breakthrough small-molecule agonist designed to target the Estrogen-Related Receptor (ERR) family, specifically $\alpha$, $\beta$, and $\gamma$. Often described in academic literature as an "exercise mimetic," this 5mg formulation is precision-dosed for sensitive research protocols focusing on cellular metabolism and the enhancement of oxidative capacity within skeletal muscle.

Key Research Mechanisms

• Mitochondrial Optimization: Research centers on its ability to stimulate mitochondrial biogenesis, increasing the number and efficiency of mitochondria to improve cellular energy production.

• Fatty Acid Oxidation: SLU-PP-332 is a primary subject in studies regarding the body’s ability to utilize adipose tissue as a primary fuel source, bypassing the immediate need for glucose.

• Muscle Fiber Adaptation: It is utilized to study the transformation of muscle tissue into a more "aerobic" state, potentially increasing endurance and fatigue resistance without external physical stimuli.

• Metabolic Syndrome Research: Investigators use this compound to model the reversal of metabolic dysfunction, focusing on its role in weight management and improved glucose homeostasis.

Product Specifications

• Concentration: 5mg

• Form: Lyophilized Powder

• Purity: >99% (HPLC Verified)

• Biological Target: Pan-ERR Agonist ($\text{ERR}\alpha, \beta, \gamma$)

• Storage: Store at -20°C for long-term stability. Maintain in a dry, dark environment to prevent molecular degradation.

LNGVIX Standards

The 5mg SLU-PP-332 is synthesized with clinical-grade precision, providing researchers with a highly stable and bioavailable compound for high-fidelity metabolic mapping and performance modeling.

LABORATORY PRECAUTION: This product is intended for laboratory research use only. It is not for human consumption, diagnostic, or therapeutic use. All research must be conducted by qualified professionals within a controlled environment.